Turn Therapeutics (TTRX) Current Assets (2024 - 2026)

Turn Therapeutics' Current Assets history runs 3 years deep, the most recent figure standing at $11.5 million for Q1 2026.

• On a quarterly basis, Current Assets changed N/A year-over-year to $11.5 million in Q1 2026; TTM through Mar 2026 was $11.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.2 million, up 373.3% from the prior year.
• Current Assets rose to $11.5 million in Q1 2026 per TTRX's latest filing, from $5.2 million in the prior quarter.
• Across five years, Current Assets topped out at $11.5 million in Q1 2026 and bottomed at $1.1 million in Q4 2024.
• The 3-year median for Current Assets is $4.2 million (2025), against an average of $5.3 million.
• Biggest YoY gain for Current Assets was 373.3% in 2025; the steepest drop was 373.3% in 2025.
• Year by year, Current Assets stood at $1.1 million in 2024, then jumped by 373.3% to $5.2 million in 2025, then jumped by 120.4% to $11.5 million in 2026.
• Per Business Quant, the three latest TTRX Current Assets figures stand at $11.5 million (Q1 2026), $5.2 million (Q4 2025), and $3.3 million (Q3 2025).